สาธารณรัฐเช็ก -
เช็ก -
USKVBL (Ústav Pro Státní Kontrolu Veterinárních Biopreparátů A Léčiv)
vetergesic multidose, 0,3 mg/ml injekční roztok pro psy a kočky 0.3 mg/ml injekční roztok
ceva santé animale - buprenorfin - injekční roztok - 0.3mg/ml - oripavinu deriváty - psi, kočky
สาธารณรัฐเช็ก -
เช็ก -
SUKL (Státní ústav pro kontrolu léčiv)
prokanazol 100mg tvrdá tobolka
pro.med.cs praha a.s. array - 9219 itrakonazol - tvrdá tobolka - 100mg - itrakonazol
สาธารณรัฐเช็ก -
เช็ก -
SUKL (Státní ústav pro kontrolu léčiv)
subutex 0,4mg sublingvální tableta
indivior europe limited, dublin array - 4670 buprenorfin-hydrochlorid - sublingvální tableta - 0,4mg - buprenorfin
สาธารณรัฐเช็ก -
เช็ก -
SUKL (Státní ústav pro kontrolu léčiv)
subutex 2mg sublingvální tableta
indivior europe limited, dublin array - 4670 buprenorfin-hydrochlorid - sublingvální tableta - 2mg - buprenorfin
สาธารณรัฐเช็ก -
เช็ก -
SUKL (Státní ústav pro kontrolu léčiv)
subutex 8mg sublingvální tableta
indivior europe limited, dublin array - 4670 buprenorfin-hydrochlorid - sublingvální tableta - 8mg - buprenorfin
สหภาพยุโรป -
เช็ก -
EMA (European Medicines Agency)
brintellix
h. lundbeck a/s - vortioxetine - depresivní porucha, major - psychoanaleptics, - léčba depresivních epizod u dospělých.
สหภาพยุโรป -
เช็ก -
EMA (European Medicines Agency)
firmagon
ferring pharmaceuticals a/s - degarelix - prostatetické novotvary - endokrinní terapie - firmagon is a gonadotrophin releasing hormone (gnrh) antagonist indicated:- for treatment of adult male patients with advanced hormone-dependent prostate cancer. - for treatment of high-risk localised and locally advanced hormone dependent prostate cancer in combination with radiotherapy. - as neo-adjuvant treatment prior to radiotherapy in patients with high-risk localised or locally advanced hormone dependent prostate cancer.
สหภาพยุโรป -
เช็ก -
EMA (European Medicines Agency)
degarelix accord
accord healthcare s.l.u. - degarelix acetate - prostatetické novotvary - other hormone antagonists and related agents - degarelix accord is a gonadotrophin releasing hormone (gnrh) antagonist indicated:for treatment of adult male patients with advanced hormone-dependent prostate cancer. for treatment of high-risk localised and locally advanced hormone dependent prostate cancer in combination with radiotherapy. as neo-adjuvant treatment prior to radiotherapy in patients with high-risk localised or locally advanced hormone dependent prostate cancer.
สาธารณรัฐเช็ก -
เช็ก -
SUKL (Státní ústav pro kontrolu léčiv)
amisulprid viatris 200mg tableta
mylan ireland limited, dublin array - 8840 amisulprid - tableta - 200mg - amisulprid
สาธารณรัฐเช็ก -
เช็ก -
SUKL (Státní ústav pro kontrolu léčiv)
amisulprid viatris 50mg tableta
mylan ireland limited, dublin array - 8840 amisulprid - tableta - 50mg - amisulprid